HEADER TRANSFERASE 16-FEB-06 2G2H TITLE A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ABL TYROSINE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: ABL TYROSINE KINASE DOMAIN; COMPND 5 SYNONYM: P150, C- ABL, ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG COMPND 6 1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABL1, ABL, JTK7; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR N.M.LEVINSON,O.KUCHMENT REVDAT 4 30-AUG-23 2G2H 1 REMARK REVDAT 3 20-OCT-21 2G2H 1 REMARK SEQADV REVDAT 2 24-FEB-09 2G2H 1 VERSN REVDAT 1 23-MAY-06 2G2H 0 JRNL AUTH N.M.LEVINSON,O.KUCHMENT,K.SHEN,M.A.YOUNG,M.KOLDOBSKIY, JRNL AUTH 2 M.KARPLUS,P.A.COLE,J.KURIYAN JRNL TITL A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE JRNL TITL 2 DOMAIN. JRNL REF PLOS BIOL. V. 4 753 2006 JRNL REFN ISSN 1544-9173 JRNL PMID 16640460 JRNL DOI 10.1371/JOURNAL.PBIO.0040144 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 51722 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 3664 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4418 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 413 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.240 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2G2H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-APR-06. REMARK 100 THE DEPOSITION ID IS D_1000036605. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 3.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57387 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10600 REMARK 200 FOR THE DATA SET : 11.0400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.41400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.990 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1M52 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.88 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M CITRIC ACID PH 3.5, 25% PEG 3350, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 52.19300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 65.74350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 52.19300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 65.74350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 245 REMARK 465 HIS A 246 REMARK 465 MET A 247 REMARK 465 SER A 248 REMARK 465 PRO A 249 REMARK 465 ASN A 250 REMARK 465 TYR A 251 REMARK 465 GLU A 524 REMARK 465 VAL A 525 REMARK 465 GLU A 526 REMARK 465 LYS A 527 REMARK 465 GLU A 528 REMARK 465 LEU A 529 REMARK 465 GLY A 530 REMARK 465 LYS A 531 REMARK 465 GLY B 245 REMARK 465 HIS B 246 REMARK 465 MET B 247 REMARK 465 SER B 248 REMARK 465 PRO B 249 REMARK 465 ASN B 250 REMARK 465 TYR B 251 REMARK 465 GLU B 524 REMARK 465 VAL B 525 REMARK 465 GLU B 526 REMARK 465 LYS B 527 REMARK 465 GLU B 528 REMARK 465 LEU B 529 REMARK 465 GLY B 530 REMARK 465 LYS B 531 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 717 O HOH A 717 2455 2.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 296 -107.68 -105.29 REMARK 500 ASP A 382 71.30 -153.04 REMARK 500 PRO A 421 92.86 -67.24 REMARK 500 TYR A 459 58.21 39.80 REMARK 500 ASP A 474 30.63 71.09 REMARK 500 LYS B 264 -82.24 -108.63 REMARK 500 LYS B 281 -62.48 -16.99 REMARK 500 LYS B 282 -74.90 -33.91 REMARK 500 SER B 284 26.83 48.73 REMARK 500 LYS B 293 171.75 -55.53 REMARK 500 PRO B 328 -134.89 -50.28 REMARK 500 PRO B 329 57.30 15.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P16 A 532 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P16 B 532 DBREF 2G2H A 248 531 UNP P00519 ABL1_HUMAN 229 512 DBREF 2G2H B 248 531 UNP P00519 ABL1_HUMAN 229 512 SEQADV 2G2H GLY A 245 UNP P00519 CLONING ARTIFACT SEQADV 2G2H HIS A 246 UNP P00519 CLONING ARTIFACT SEQADV 2G2H MET A 247 UNP P00519 CLONING ARTIFACT SEQADV 2G2H PRO A 415 UNP P00519 HIS 396 ENGINEERED MUTATION SEQADV 2G2H GLY B 245 UNP P00519 CLONING ARTIFACT SEQADV 2G2H HIS B 246 UNP P00519 CLONING ARTIFACT SEQADV 2G2H MET B 247 UNP P00519 CLONING ARTIFACT SEQADV 2G2H PRO B 415 UNP P00519 HIS 396 ENGINEERED MUTATION SEQRES 1 A 287 GLY HIS MET SER PRO ASN TYR ASP LYS TRP GLU MET GLU SEQRES 2 A 287 ARG THR ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY SEQRES 3 A 287 GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SEQRES 4 A 287 SER LEU THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR SEQRES 5 A 287 MET GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET SEQRES 6 A 287 LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY SEQRES 7 A 287 VAL CYS THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU SEQRES 8 A 287 PHE MET THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU SEQRES 9 A 287 CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR SEQRES 10 A 287 MET ALA THR GLN ILE SER SER ALA MET GLU TYR LEU GLU SEQRES 11 A 287 LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN SEQRES 12 A 287 CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP SEQRES 13 A 287 PHE GLY LEU SER ARG LEU MET THR GLY ASP THR TYR THR SEQRES 14 A 287 ALA PRO ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA SEQRES 15 A 287 PRO GLU SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER SEQRES 16 A 287 ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA SEQRES 17 A 287 THR TYR GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER SEQRES 18 A 287 GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU SEQRES 19 A 287 ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET SEQRES 20 A 287 ARG ALA CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER SEQRES 21 A 287 PHE ALA GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN SEQRES 22 A 287 GLU SER SER ILE SER ASP GLU VAL GLU LYS GLU LEU GLY SEQRES 23 A 287 LYS SEQRES 1 B 287 GLY HIS MET SER PRO ASN TYR ASP LYS TRP GLU MET GLU SEQRES 2 B 287 ARG THR ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY SEQRES 3 B 287 GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SEQRES 4 B 287 SER LEU THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR SEQRES 5 B 287 MET GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET SEQRES 6 B 287 LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY SEQRES 7 B 287 VAL CYS THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU SEQRES 8 B 287 PHE MET THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU SEQRES 9 B 287 CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR SEQRES 10 B 287 MET ALA THR GLN ILE SER SER ALA MET GLU TYR LEU GLU SEQRES 11 B 287 LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN SEQRES 12 B 287 CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP SEQRES 13 B 287 PHE GLY LEU SER ARG LEU MET THR GLY ASP THR TYR THR SEQRES 14 B 287 ALA PRO ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA SEQRES 15 B 287 PRO GLU SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER SEQRES 16 B 287 ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA SEQRES 17 B 287 THR TYR GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER SEQRES 18 B 287 GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU SEQRES 19 B 287 ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET SEQRES 20 B 287 ARG ALA CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER SEQRES 21 B 287 PHE ALA GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN SEQRES 22 B 287 GLU SER SER ILE SER ASP GLU VAL GLU LYS GLU LEU GLY SEQRES 23 B 287 LYS HET P16 A 532 29 HET P16 B 532 29 HETNAM P16 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL) HETNAM 2 P16 PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE HETSYN P16 PD166326 FORMUL 3 P16 2(C21 H16 CL2 N4 O2) FORMUL 5 HOH *413(H2 O) HELIX 1 1 GLU A 257 THR A 259 5 3 HELIX 2 2 GLY A 268 GLN A 271 5 4 HELIX 3 3 LYS A 282 SER A 284 5 3 HELIX 4 4 GLU A 298 LYS A 310 1 13 HELIX 5 5 ASN A 341 CYS A 349 1 9 HELIX 6 6 ASN A 355 LYS A 376 1 22 HELIX 7 7 ALA A 384 ARG A 386 5 3 HELIX 8 8 GLU A 392 HIS A 394 5 3 HELIX 9 9 PRO A 421 THR A 425 5 5 HELIX 10 10 ALA A 426 ASN A 433 1 8 HELIX 11 11 SER A 436 THR A 453 1 18 HELIX 12 12 ASP A 463 SER A 465 5 3 HELIX 13 13 GLN A 466 LYS A 473 1 8 HELIX 14 14 PRO A 484 TRP A 495 1 12 HELIX 15 15 ASN A 498 ARG A 502 5 5 HELIX 16 16 SER A 504 ILE A 521 1 18 HELIX 17 17 GLU B 257 THR B 259 5 3 HELIX 18 18 GLY B 268 GLN B 271 5 4 HELIX 19 19 GLU B 298 ILE B 312 1 15 HELIX 20 20 ASN B 341 CYS B 349 1 9 HELIX 21 21 ASN B 355 LYS B 376 1 22 HELIX 22 22 ALA B 384 ARG B 386 5 3 HELIX 23 23 GLU B 392 HIS B 394 5 3 HELIX 24 24 PRO B 421 THR B 425 5 5 HELIX 25 25 ALA B 426 ASN B 433 1 8 HELIX 26 26 SER B 436 THR B 453 1 18 HELIX 27 27 ASP B 463 SER B 465 5 3 HELIX 28 28 GLN B 466 LYS B 473 1 8 HELIX 29 29 PRO B 484 TRP B 495 1 12 HELIX 30 30 ASN B 498 ARG B 502 5 5 HELIX 31 31 SER B 504 SER B 519 1 16 SHEET 1 A 5 ILE A 261 LYS A 266 0 SHEET 2 A 5 GLU A 274 TRP A 280 -1 O GLU A 277 N HIS A 265 SHEET 3 A 5 LEU A 285 THR A 291 -1 O VAL A 287 N GLY A 278 SHEET 4 A 5 TYR A 331 GLU A 335 -1 O ILE A 332 N LYS A 290 SHEET 5 A 5 LEU A 320 CYS A 324 -1 N LEU A 321 O ILE A 333 SHEET 1 B 2 PHE A 378 HIS A 380 0 SHEET 2 B 2 LEU A 403 ARG A 405 -1 O SER A 404 N ILE A 379 SHEET 1 C 2 CYS A 388 GLY A 391 0 SHEET 2 C 2 LEU A 395 VAL A 398 -1 O LYS A 397 N LEU A 389 SHEET 1 D 2 TYR A 412 THR A 413 0 SHEET 2 D 2 LYS A 434 PHE A 435 -1 O PHE A 435 N TYR A 412 SHEET 1 E 5 ILE B 261 LYS B 266 0 SHEET 2 E 5 VAL B 275 TRP B 280 -1 O GLU B 277 N HIS B 265 SHEET 3 E 5 LEU B 285 LEU B 292 -1 O VAL B 287 N GLY B 278 SHEET 4 E 5 PHE B 330 GLU B 335 -1 O ILE B 332 N LYS B 290 SHEET 5 E 5 LEU B 320 CYS B 324 -1 N LEU B 321 O ILE B 333 SHEET 1 F 2 PHE B 378 HIS B 380 0 SHEET 2 F 2 LEU B 403 ARG B 405 -1 O SER B 404 N ILE B 379 SHEET 1 G 2 CYS B 388 VAL B 390 0 SHEET 2 G 2 VAL B 396 VAL B 398 -1 O LYS B 397 N LEU B 389 SHEET 1 H 2 TYR B 412 THR B 413 0 SHEET 2 H 2 LYS B 434 PHE B 435 -1 O PHE B 435 N TYR B 412 CISPEP 1 PRO A 328 PRO A 329 0 -0.34 SITE 1 AC1 17 TYR A 272 ALA A 288 VAL A 289 LYS A 290 SITE 2 AC1 17 MET A 309 ILE A 332 THR A 334 GLU A 335 SITE 3 AC1 17 PHE A 336 MET A 337 THR A 338 GLY A 340 SITE 4 AC1 17 LEU A 389 ALA A 399 ASP A 400 PHE A 401 SITE 5 AC1 17 HOH A 646 SITE 1 AC2 16 TYR B 272 ALA B 288 LYS B 290 GLU B 305 SITE 2 AC2 16 MET B 309 ILE B 332 THR B 334 GLU B 335 SITE 3 AC2 16 PHE B 336 MET B 337 GLY B 340 LEU B 389 SITE 4 AC2 16 ALA B 399 ASP B 400 PHE B 401 HOH B 664 CRYST1 104.386 131.487 56.499 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009580 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007605 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017699 0.00000